<DOC>
	<DOCNO>NCT00721188</DOCNO>
	<brief_summary>The primary objective study ass pharmacokinetics Venofer ( Iron Sucrose Injection ) NDD-CKD pediatric patient .</brief_summary>
	<brief_title>Iron Sucrose Non-Dialysis Dependent ( NDD-CKD ) Pediatric Patients</brief_title>
	<detailed_description />
	<mesh_term>Ferric oxide , saccharated</mesh_term>
	<mesh_term>Hematinics</mesh_term>
	<criteria>Age &gt; = 12 &lt; = 16 year Parent and/or legal guardian able give inform consent Subject able give write assent participate study NDDCKD define : kidney damage 3 month longer , GFR &lt; 60 3 month longer Hemoglobin indicative anemia Ferritin indicative iron deficiency anemia If appropriate , subject must willing use accept form birth control time screen followup period Known history hypersensitivity component Venofer Parenteral iron within 14 day screen visit Dialysis dependentCKD Chronic serious active infection Pregnancy lactation Subjects cause iron deficiency anemia CKD Blood transfusion within last month anticipate study Body weight &lt; 55 pound Received investigational drug within 30 day screen</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>16 Years</maximum_age>
	<verification_date>April 2015</verification_date>
</DOC>